Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage
Marcel Blaise, Dominique Pateron, Jean‐Claude Trinchet, Serge Levacher, Michel Beaugrand, Jean‐Louis Pourriat – 1 July 1994 – This randomized prospective study was aimed at assessing the efficiency of a systemic antibiotic therapy for the prevention of bacterial infections in cirrhotic patients with gastrointestinal hemorrhage by ruptured esophageal varices. For 15 mo, all patients hospitalized with no infection on admission, were included in the study. Starting on admission day, patients in group A received ofloxacin (400 mg/day) for 10 days, first intravenously then orally.